Type 2 diabetes mellitus DAPAMED is indicated in adults aged 18 years and older for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise* As monotherapy when metformin is considered inappropriate due to intolerance.* In addition to other medicinal products for the treatment of type 2 diabetes.Heart FailureDAPAMED is indicated in adults for the treatment of symptomatic chronic heart failureChronic kidney diseaseDAPAMED is indicated in adults for the treatment of chronic kidney disease